Quintanilla I, Azeroglu B, Sagar M, Stracker T, Denchi E, Pegoraro G
bioRxiv. 2025; .
PMID: 39990381
PMC: 11844499.
DOI: 10.1101/2025.02.15.638448.
Laemmerer A, Lehmann C, Mayr L, Bruckner K, Gabler L, Senfter D
Neuro Oncol. 2024; 27(3):811-827.
PMID: 39556024
PMC: 11889718.
DOI: 10.1093/neuonc/noae228.
Zeng F, Chen Y, Lin J
BMC Cancer. 2024; 24(1):1386.
PMID: 39529015
PMC: 11555837.
DOI: 10.1186/s12885-024-13146-0.
Salgado S, Abreu P, Moleirinho B, Guedes D, Larcombe L, Azzalin C
EMBO Rep. 2024; 25(12):5294-5315.
PMID: 39468351
PMC: 11624207.
DOI: 10.1038/s44319-024-00295-3.
Wang B, Kou H, Wang Y, Zhang Q, Jiang D, Wang J
Cell Death Dis. 2024; 15(10):761.
PMID: 39426946
PMC: 11490576.
DOI: 10.1038/s41419-024-07116-4.
A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.
Froney M, Cook C, Cadiz A, Flinter K, Ledeboer S, Chan B
ACS Pharmacol Transl Sci. 2024; 7(9):2799-2819.
PMID: 39296266
PMC: 11406699.
DOI: 10.1021/acsptsci.4c00251.
Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay.
Burrow T, Koneru B, Macha S, Sun W, Barr F, Triche T
Front Oncol. 2024; 14:1399442.
PMID: 39224814
PMC: 11366626.
DOI: 10.3389/fonc.2024.1399442.
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles.
Flynn A, Pattison A, Balachander S, Boehm E, Bowen B, Dwight T
Res Sq. 2024; .
PMID: 38978571
PMC: 11230496.
DOI: 10.21203/rs.3.rs-4410500/v1.
Extrachromosomal telomere DNA derived from excessive strand displacements.
Lee J, Lee J, Sohn E, Taglialatela A, OSullivan R, Ciccia A
Proc Natl Acad Sci U S A. 2024; 121(19):e2318438121.
PMID: 38696464
PMC: 11087782.
DOI: 10.1073/pnas.2318438121.
Distinct modes of telomere synthesis and extension contribute to Alternative Lengthening of Telomeres.
Lu R, Nelson C, Rogers S, Cesare A, Sobinoff A, Pickett H
iScience. 2024; 27(1):108655.
PMID: 38213617
PMC: 10783591.
DOI: 10.1016/j.isci.2023.108655.
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the and Genes.
Djos A, Thombare K, Vaid R, Gaarder J, Umapathy G, Reinsbach S
Cancers (Basel). 2023; 15(24).
PMID: 38136279
PMC: 10741428.
DOI: 10.3390/cancers15245732.
Telomere maintenance in African trypanosomes.
Li B
Front Mol Biosci. 2023; 10:1302557.
PMID: 38074093
PMC: 10704157.
DOI: 10.3389/fmolb.2023.1302557.
Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.
Rosso I, Jones-Weinert C, Rossiello F, Cabrini M, Brambillasca S, Munoz-Sagredo L
Nat Commun. 2023; 14(1):7086.
PMID: 37925537
PMC: 10625592.
DOI: 10.1038/s41467-023-42831-0.
Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer.
Mori J, Keegan J, Flynn R, Heaphy C
J Clin Pathol. 2023; 77(2):82-86.
PMID: 37890990
PMC: 11450735.
DOI: 10.1136/jcp-2023-209005.
Telomeric DNA breaks in human induced pluripotent stem cells trigger ATR-mediated arrest and telomerase-independent telomere damage repair.
Estep K, Tobias J, Fernandez R, Beveridge B, Johnson F
J Mol Cell Biol. 2023; 16(3).
PMID: 37771090
PMC: 11429528.
DOI: 10.1093/jmcb/mjad058.
Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma.
Kreilmeier-Berger T, Aupperle-Lellbach H, Reifinger M, Horstke N, Holzmann K, Kleiter M
Cancers (Basel). 2023; 15(17).
PMID: 37686490
PMC: 10487132.
DOI: 10.3390/cancers15174214.
Telomerase-independent survival leads to a mosaic of complex subtelomere rearrangements in .
Chaux F, Agier N, Garrido C, Fischer G, Eberhard S, Xu Z
Genome Res. 2023; 33(9):1582-1598.
PMID: 37580131
PMC: 10620057.
DOI: 10.1101/gr.278043.123.
Distinct characteristics of two types of alternative lengthening of telomeres in mouse embryonic stem cells.
Sung S, Kim E, Niida H, Kim C, Lee J
Nucleic Acids Res. 2023; 51(17):9122-9143.
PMID: 37496110
PMC: 10516625.
DOI: 10.1093/nar/gkad617.
NPCs and APBs: two HUBs of non-canonical homology-based recombination at telomeres?.
Aguilera P, Dubarry M, Geli V, Simon M
Cell Cycle. 2023; 22(10):1163-1168.
PMID: 37128641
PMC: 10193864.
DOI: 10.1080/15384101.2023.2206350.
ATRX/DAXX: Guarding the Genome against the Hazards of ALT.
Clatterbuck Soper S, Meltzer P
Genes (Basel). 2023; 14(4).
PMID: 37107548
PMC: 10137841.
DOI: 10.3390/genes14040790.